Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity
- PMID: 8632481
- DOI: 10.1006/jmbi.1996.0218
Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity
Abstract
A number of biochemical properties differ dramatically among homologues within the pancreatic ribonuclease superfamily. Human pancreatic ribonuclease (hRNase) has high enzyme activity, extreme sensitivity to ribonuclease inhibitor (RI) and is non-toxic, whereas a homologous RNase from frog eggs, called onconase, has much lower enzyme activity, is not sensitive to RI and is cytotoxic to cancer cell lines and animals. To explore the structural basis of these differences among members in the RNAse family we synthesized genes for onconase, hRNase, a mutant onconase (K9Q) and onconase-hRNase N-terminal hybrids and expressed the proteins in Escherichia coli with final yields of 10 to 50 mg per liter of culture after purification. A recombinant version of onconase with an N-terminal methionine instead of the native pyroglutamyl residue had decreased cytotoxicity and enzyme activity. Cleavage of the recombinant onconase Met-1 residue, and cyclization of the Gln1 residue to reform the pyroglutamyl N terminus, reconstituted cytotoxicity and enzyme activity. Thus a unique role of the pyroglutamyl residue in the active site of amphibian RNases is indicated. Replacement of one to nine residues of onconase with the homologous residues of hRNase increased the enzymatic activity against most of the substrates tested with a simultaneous shift in the enzyme specificity from high preference for poly(U) to slight preference for poly(C). Cytotoxicity of the chimera decreased, dissociating cytotoxicity from enzymatic activity. The molecular basis for the low binding affinity of onconase for RI has been examined experimentally with the recombinant RNases and by fitting onconase and RNase A structures to the coordinates from the recently published RNase A-RI complex.
Similar articles
-
A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.J Biol Chem. 1993 May 15;268(14):10686-93. J Biol Chem. 1993. PMID: 8486718
-
Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.Protein Eng. 1997 Apr;10(4):463-70. doi: 10.1093/protein/10.4.463. Protein Eng. 1997. PMID: 9194172
-
Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.Biochemistry. 1998 Apr 14;37(15):5173-83. doi: 10.1021/bi972147h. Biochemistry. 1998. PMID: 9548748
-
Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.Curr Pharm Biotechnol. 2008 Jun;9(3):215-25. doi: 10.2174/138920108784567245. Curr Pharm Biotechnol. 2008. PMID: 18673287 Free PMC article. Review.
-
Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.Curr Pharm Biotechnol. 2008 Jun;9(3):185-9. doi: 10.2174/138920108784567344. Curr Pharm Biotechnol. 2008. PMID: 18673284 Free PMC article. Review.
Cited by
-
The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens.Nucleic Acids Res. 2003 Sep 15;31(18):5247-55. doi: 10.1093/nar/gkg746. Nucleic Acids Res. 2003. PMID: 12954760 Free PMC article.
-
A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7768-73. doi: 10.1073/pnas.96.14.7768. Proc Natl Acad Sci U S A. 1999. PMID: 10393896 Free PMC article.
-
Towards tricking a pathogen's protease into fighting infection: the 3D structure of a stable circularly permuted onconase variant cleavedby HIV-1 protease.PLoS One. 2013;8(1):e54568. doi: 10.1371/journal.pone.0054568. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349931 Free PMC article.
-
Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.Front Pharmacol. 2019 Sep 13;10:1019. doi: 10.3389/fphar.2019.01019. eCollection 2019. Front Pharmacol. 2019. PMID: 31572192 Free PMC article. Review.
-
Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway.J Cell Sci. 2003 Jan 15;116(Pt 2):313-24. doi: 10.1242/jcs.00214. J Cell Sci. 2003. PMID: 12482917 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous